Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Keri E. Lunsford, Andrew Scott, Pratima Sharma, Julius Wilder – 31 May 2021 – The COVID‐19 pandemic and social justice movement have highlighted the impact of social determinants of health (SDOH) and structural racism in the United States on both access to care and patient outcomes. With the evaluation for liver transplantation being a highly subjective process, there are multiple ways for SDOH to place vulnerable patients at a disadvantage.

Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Keri E. Lunsford, Andrew Scott, Pratima Sharma, Julius Wilder – 31 May 2021 – The COVID‐19 pandemic and social justice movement have highlighted the impact of social determinants of health (SDOH) and structural racism in the United States on both access to care and patient outcomes. With the evaluation for liver transplantation being a highly subjective process, there are multiple ways for SDOH to place vulnerable patients at a disadvantage.

Elizabeth S. Aby, Russell Rosenblatt – 31 May 2021

Ioannis A. Ziogas, W. Kelly Wu, Lea K. Matsuoka, Anita K. Pai, Einar T. Hafberg, Lynette A. Gillis, Thomas M. Morgan, Sophoclis P. Alexopoulos – 30 May 2021 – Liver transplantation (LT) for children with urea cycle disorders (UCDs) is capable of correcting the enzymatic defect and preventing progressive neurologic injury. We describe the characteristics and outcomes of pediatric LT recipients with UCDs. We identified all pediatric (<18 years) LT candidates with UCDs in the United Network for Organ Sharing (UNOS) database (February 2002 to September 2020).

Brian T. Lee, Michele M. Tana, Jeffrey A. Kahn, Lily Dara – 30 May 2021 – Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant‐related disparities have all been reported in racial and ethnic minorities such as Black and Latinx patients with autoimmune liver diseases.

Brian T. Lee, Michele M. Tana, Jeffrey A. Kahn, Lily Dara – 30 May 2021 – Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant‐related disparities have all been reported in racial and ethnic minorities such as Black and Latinx patients with autoimmune liver diseases.

Dempsey L. Hughes, Pratima Sharma – 29 May 2021

Paola A. Vargas, Emily K.E. McCracken, Indika Mallawaarachchi, Sarah J. Ratcliffe, Curtis Argo, Shawn Pelletier, Victor M. Zaydfudim, Jose Oberholzer, Nicolas Goldaracena – 29 May 2021 – Maximizing liver graft volume benefits the living donor liver recipient. Whether maximizing graft volume negatively impacts living donor recovery and outcomes remains controversial.

Alessio Lepore, Pui Man Choy, Nathan C.W. Lee, Maria Annunziata Carella, Rosy Favicchio, Marco A. Briones‐Orta, Shannon S. Glaser, Gianfranco Alpini, Clive D’Santos, Reuben M. Tooze, Mihaela Lorger, Wing‐Kin Syn, Athanasios Papakyriakou, Georgios Giamas, Concetta Bubici, Salvatore Papa – 27 May 2021

Dor Yoeli, Whitney E. Jackson, Megan A. Adams, Michael E. Wachs, Shikha S. Sundaram, Anna Sater, Jaime R. Cisek, Rashikh A. Choudhury, Trevor L. Nydam, James J. Pomposelli, Kendra D. Conzen, Michael S. Kriss, James R. Burton, Elizabeth A. Pomfret – 27 May 2021 – A gap exists between the demand for pediatric liver transplantation and the supply of appropriate size‐matched donors. We describe our center’s experience with pediatric liver transplantation using anonymous nondirected living liver donors (ND‐LLD).